mTOR inhibitors such as rapamycin and its analogs (everolimus (RAD001), deforolimus (AP23573), and temsirolimus (CCI-779)) suppress cellular growth and proliferation and are considered to be effective for glioblastoma treatment [90,91]. Here, MTOR is linked to glioblastoma.